Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.

DY, Kim; YD, Joo; SN, Lim; SD, Kim; JH, Lee; JH, Lee; DH, Kim; K, Kim; CW, Jung; I, Kim; SS, Yoon; S, Park; JS, Ahn; DH, Yang; JJ, Lee; HS, Lee; YS, Kim; YC, Mun; H, Kim; JH, Park; JH, Moon; SK, Sohn; SM, Lee; WS, Lee; KH, Kim; JH, Won; MS, Hyun; J, Park; JH, Lee; HJ, Shin; JS, Chung; H, Lee; HS, Eom; GW, Lee; YU, Cho; S, Jang; CJ, Park; HS, Chi; KH, Lee

doi:10.1182/blood-2015-03-636548

Public

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.

Shared by NobleBlocks on Jun 11, 2015 • 12:00 AM UTC

Authors:

Kim DY

Joo YD

Lim SN

Abstract

We investigated the effects of nilotinib plus multiagent chemotherapy, followed by consolidation/maintenance or allogeneic hematopoietic cell transplantation (allo-HCT) for adult patients with newly diagnosed Philadelphia-positive (Ph-pos) acute lymphoblastic leukemia (ALL). Study subjects received ...

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!